Stay updated on Daratumumab in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.

Latest updates to the Daratumumab in AL Amyloidosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new Blood publication citation for ANDROMEDA survival analysis was added to the Publications section, and the page revision history shows an update to v3.5.4 from v3.5.3.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe ClinicalTrials.gov page’s displayed revision/version number was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.5.0 deployed, replacing v3.4.3. No user-facing changes to the study details or core content.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be metadata only and does not change study content or user-facing functionality.SummaryDifference0.0%

- Check113 days agoChange DetectedAdded Amyloidosis as a topic and the Genetic and Rare Diseases Information Center resource. Updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check120 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Daratumumab in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.